WebOct 21, 2015 · Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. WebCepheid Description Cepheid was incorporated in the State of California on March 4, 1996. The Company is a molecular diagnostics company that develops, manufactures and …
CEPHEID (CPHD) Stock Price Today, Quote & News
WebDec 19, 2007 · Only two of the 21 firms that comprise the BCW Index saw their stock prices decline during the year. While several firms’ shares rose more than 50 percent, Cepheid topped the list of gainers, rising an astonishing 194 percent so far this year. WebJun 14, 2012 · SUNNYVALE, Calif., June 14, 2012 /PRNewswire/ -- Cepheid today welcomed UNITAID's announcement that it has approved funding of $30 million to scale up access to the ground-breaking... March 1, 2024 ... End-of-day quote Nasdaq - -USD ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ ... new york college 529 savings plan
DHR Stock Price and Chart — NYSE:DHR — TradingView
WebSr. Customer Support Engineer - Bhubhneshwar. Beckman Coulter Diagnostics Kolkata, West Bengal, India Customer Support R1235515. Cepheid was founded in March 1996 by Thomas Gutshall, Bill McMillan, Dr. Kurt Petersen, Dr. Greg Kovacs, Steven Young and Dr. Allen Northrup. The company went public in 2000. The initial public offering was June 21, 2000 at US$6 per share. Cepheid stock was listed on the Nasdaq under the ticker symbol CPHD until it was acquired by Danaher in 2016. WebCEPHEID (NASDAQ:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CEPHEID Nasdaq: Nasdaq new york coffee in budapest